• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Novavax, Inc. - Common Stock (NQ: NVAX )

    8.510 -0.130 (-1.50%)
    Streaming Delayed Price Updated: 1:00 PM EST, Dec 24, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Novavax, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    56 57 Next >
    Are You Ready To Trade Biotech Stocks At The Cusp Of A Bear Market?
    It’s not a bear market for biotech yet it just feels that way because recent trends are down and healthcare stocks are not a stabilizing force. 
    Via Talk Markets
    Topics ETFs Stocks / Equities
    Peering Into Novavax's Recent Short Interest
    Via Benzinga
    Jim Cramer Is 'Not A Fan' Of Novavax, Says This Tech Stock Is 'Expensive'
    Via Benzinga
    Deal Dispatch: Ubisoft In Buyout Talks, Dental Supplier Explores Sale, Beloved Drive-Through Goes Bankrupt
    Dental supply maker Patterson Companies Inc announced Thursday that it is exploring strategic options, including a sale or merger, to boost shareholder value. 
    Via Benzinga
    Topics Supply Chain
    Exposures Supply Chain
    Earnings Scheduled For November 12, 2024
    Via Benzinga
    Earnings Outlook For Novavax
    Via Benzinga
    Looking Into Novavax's Recent Short Interest
    Via Benzinga
    How Is The Market Feeling About Novavax?
    Via Benzinga
    2 Beaten-Down "Pandemic Stocks" to Consider for Contrarian Investors
    Via The Motley Fool
    Wegovy Maker Novo Nordisk To Buy Novavax's Czech Republic Manufacturing Facility For $200 Million
    Novavax sells Czech manufacturing facility to Novo Nordisk for $200 million, aiming to cut costs by $80 million annually and support its growth strategy. 
    Via Benzinga
    Is Biotech’s Bull Run Over? Examining Election Impacts
    The biotech sector's breakout attempt post-election reversed sharply, with ETFs like IBB and XBI falling and invalidating the long-term bullish setup. 
    Via MarketBeat
    Topics ETFs Government
    Exposures Political
    Powell Speaks The Truth - Market Does Not Like It, Consternation About Kennedy, Gaetz, And Hegseth
    To gain an edge, this is what you need to know today. 
    Via Benzinga
    Pfizer, Moderna, Novavax Take A Beating After Trump Taps Kennedy To Head Up HHS
    President-elect Donald Trump tapped widely known vaccine skeptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services. 
    Via Investor's Business Daily
    Topics Government
    Exposures Political
    WHO Calls Vaccines 'Absolutely Critical' As Trump's Appointment Of RFK Jr Pulls Pzifer, Moderna Stocks Downhill
    Trump's decision to appoint Kennedy, known for his vaccine skepticism, has sparked significant attention. 
    Via Benzinga
    Topics Government
    Exposures Political
    US Stocks Likely To Open In Red After Jerome Powell Says No Need To Be 'In A Hurry' On Rate Cuts: Tesla, TSMC And Domino's In Focus
    U.S. stocks could open on a negative note on Friday after the Federal Reserve chair Jerome Powell's comments on Thursday that the economy is showing enough strength that there is no need to be "in a... 
    Via Benzinga
    Topics Economy
    Exposures Economy Interest Rates
    Trump Taps RFK Jr. For Health Secretary Role, Sends 5 Vaccine Stocks Lower
    Trump may appoint Robert F. Kennedy Jr. as HHS Secretary, stirring mixed reactions. Kennedy's views on vaccines could reshape policies and affect vaccine stocks. 
    Via Benzinga
    Topics Government
    Exposures Political
    Novavax Lowers 2024 Forecast Despite Q3 Revenue Beat, Stock Falls
    Novavax reports Q3 2024 sales of $84.5 million, beating estimates, with a net loss of $121 million. EPS improves, FDA approves new vaccine, and revenue guidance is lowered. 
    Via Benzinga
    Exposures Product Safety
    FDA Gives Green Signal To Novavax's COVID-19-Influenza Combo Vaccine Late-Stage Trial
    FDA lifts clinical hold on Novavax's COVID-19-influenza combo vaccine, clearing path for Phase 3 trials. Novavax to resume trial activities soon. 
    Via Benzinga
    Exposures Product Safety
    Smaller Cap Biotechs Are In Season: How Are We Doing?
    SMID biotech stocks still see a lot of speculative interest except for a brief sell-off on August 5 when the XBI touched $91.The XBI is near its 2024 high in the $103 range. 
    Via Talk Markets
    Why Is COVID-19 Vaccine Maker Novavax Stock Trading Lower On Wednesday?
    Novavax ends UK COVID-19 vaccine contract, agreeing to repay $123.8M in quarterly installments by 2027 as part of settlement. 
    Via Benzinga
    Exposures COVID-19
    3 Spooky Signs That You're About to Lose Your Money on a Healthcare Stock Investment
    Knowing these will help you avoid making suboptimal investing decisions. 
    Via The Motley Fool
    This Vaccine Stock Just Dropped by 20%: Should You Buy the Dip?
    Let's look beyond this piece of bad news from regulators. 
    Via The Motley Fool
    How Bad Is This News for Novavax?
    Novavax stock fell 20% in one trading session on the news. 
    Via The Motley Fool
    Robinhood, Novavax, Phunware, Lucid Group, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
    On Wednesday, major U.S. indices saw gains, with the Dow Jones Industrial Average climbing nearly 0.8% to 43,077.70. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Nasdaq Moves Higher; Morgan Stanley Profit Beats Estimates
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Dow Jumps 250 Points; U.S. Bancorp Earnings Top Views
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    FDA Puts Speed Breaker On Novavax's COVID/Flu Combo Shot Trial On Concerns Related To Damaged Nerves
    Novavax stock dips as the FDA pauses its COVID-19-influenza vaccine trials following a serious adverse event. 
    Via Benzinga
    Exposures Product Safety
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    What's Going On With Novavax Stock Today?
    Novavax Inc (NASDAQ:NVAX) shares are bouncing around Wednesday, pulling back after popping in early trading. The company announced that it received European marketing authorization for its Nuvaxovid... 
    Via Benzinga
    Exposures COVID-19
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    56 57 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.